Taylor Wealth Management Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $416K | Sell |
1,477
-1
| -0.1% | -$282 | 0.24% | 47 |
|
|
2022
Q1 | $386K | Buy |
1,478
+5
| +0.3% | +$1.31K | 0.16% | 52 |
|
|
2021
Q4 | $323K | Sell |
1,473
-250
| -15% | -$54.8K | 0.11% | 57 |
|
|
2021
Q3 | $313K | Buy |
1,723
+240
| +16% | +$43.6K | 0.11% | 59 |
|
|
2021
Q2 | $299K | Buy |
1,483
+90
| +6% | +$18.1K | 0.11% | 57 |
|
|
2021
Q1 | $299K | Buy |
1,393
+30
| +2% | +$6.44K | 0.11% | 59 |
|
|
2020
Q4 | $322K | Buy |
1,363
+311
| +30% | +$73.5K | 0.12% | 52 |
|
|
2020
Q3 | $286K | Buy |
+1,052
| New | +$286K | 0.13% | 46 |
|
|
2019
Q1 | – | Sell |
-350
| Closed | -$58K | – | 112 |
|
|
2018
Q4 | $58K | Hold |
350
| – | – | 0.03% | 58 |
|
|
2018
Q3 | $67K | Sell |
350
-500
| -59% | -$95.7K | 0.03% | 69 |
|
|
2018
Q2 | $144K | Hold |
850
| – | – | 0.06% | 55 |
|
|
2018
Q1 | $139K | Hold |
850
| – | – | 0.07% | 54 |
|
|
2017
Q4 | $127K | Sell |
850
-100
| -11% | -$14.9K | 0.05% | 72 |
|
|
2017
Q3 | $144K | Hold |
950
| – | – | 0.06% | 72 |
|
|
2017
Q2 | $122K | Hold |
950
| – | – | 0.06% | 73 |
|
|
2017
Q1 | $104K | Sell |
950
-6,341
| -87% | -$694K | 0.05% | 79 |
|
|
2016
Q4 | $537K | Sell |
7,291
-2,770
| -28% | -$204K | 0.25% | 42 |
|
|
2016
Q3 | $877K | Sell |
10,061
-27,648
| -73% | -$2.41M | 0.39% | 39 |
|
|
2016
Q2 | $3.24M | Sell |
37,709
-7,037
| -16% | -$605K | 1.3% | 33 |
|
|
2016
Q1 | $3.56M | Sell |
44,746
-885
| -2% | -$70.4K | 1.68% | 28 |
|
|
2015
Q4 | $5.74M | Buy |
45,631
+21,701
| +91% | +$2.73M | 2.47% | 16 |
|
|
2015
Q3 | $2.49M | Buy |
+23,930
| New | +$2.49M | 1.2% | 29 |
|